Lauren Santye, Assistant Editor

Cancer patient Beth Wallace provides advice to patients with leiomyosarcoma, as well as to women with cancer in general.

A fixed-dose combination of bictegravir and emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) was non-inferior to boosted protease inhibitor (bPI)-based regimens in virologically suppressed adults with HIV, according to a recently-published phase 3 study.

Achieving National HIV/AIDs target goal could prevent an estimated 200,000 deaths over 20 years, according to a study recently published in the Journal of Infectious Diseases.

Beth Wallace was always one to advocate for herself in different areas of her life, but when it came to her health, she left it to the doctors. Here, she discusses the importance of education and being your own advocate.

Consistency among caregivers can be an important factor for patients undergoing treatment for cancer.

The investigational regimen may be appropriate for a broad range of HIV-positive patients.

Reducing the cost of antiretroviral therapy could produce even more savings in the treatment of HIV.

Top news of the day from across the health care landscape.

Cancer patient Beth Wallace speaks about her support system and the impact they have made on her life.

The pharma giant will now focus on its PD-1 cancer immunotherapy Keytruda.

Ramping up programs for injection drug users is a key part in preventing transmission of hepatitis C.

Top news of the day from across the health care landscape.

Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.

Outcomes and accreditation measures are among the key factors in building a successful specialty pharmacy, according to a session at the annual NASP meeting.

Top news of the day from across the health care landscape.

In part 2, Beth Wallace describes the events leading up to her diagnosis with leiomyosarcoma.

Data from a phase 2 trial demonstrates positive results on improving the disabling symptoms of a rare form of autism.

Pertuzumab-based regimen shows promise treating adjuvant treatment of HER2-positive early breast cancer.

Genentech is seeking approval for Perjeta used in combination with trastuzumab and chemotherapy for adjuvant treatment of HER2-positive early breast cancer.

Consolidative radiation followed by chemotherapy could play a key role in future survival outcomes among patients with non-small cell lung cancer.

Top news of the day from across the health care landscape.

New findings suggest alterations in this process may trigger cancer progression.

Certified specialty pharmacists have greater opportunities and credibility in the growing market, according to a session at the annual NASP meeting.

Top news of the day from across the health care landscape.

The 3-in-1 antibody protected laboratory monkeys from SHIV.

In part 1 of 2, Beth Wallace shares her journey leading up to her diagnosis with leiomyosarcoma.

Abemaciclib treats adults with hormone receptor-positive, human epidemical growth factor receptor-negative advanced or metastatic breast cancer that progressed after endocrine therapy.

Verzenio can be administered as a stand-alone treatment to patients previously treated with endocrine therapy and chemotherapy.

Ron Lanton III, Esq, discusses all things biosimilar during a session at the National Association of Specialty Pharmacy (NASP) Annual Meeting and Educational Conference.

Promotion of healthy lifestyle changes are crucial among HIV-positive patients cured of hepatitis C.